• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.

作者信息

Falkson G, Van der Merwe A M, Falkson H C

出版信息

Cancer Chemother Rep. 1972 Oct;56(5):671-7.

PMID:4569061
Abstract
摘要

相似文献

1
Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.5-（3,3-双（2-氯乙基）-1-三氮烯基）咪唑-4-甲酰胺（NSC-82196）治疗转移性恶性黑色素瘤的临床经验
Cancer Chemother Rep. 1972 Oct;56(5):671-7.
2
5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma.
Cancer Chemother Rep. 1972 Oct;56(5):667-70.
3
[Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma].[采用5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺（达卡巴嗪；NSC-45388）、1,3-双(2-氯乙基)-1-亚硝基脲（卡莫司汀，NSC-409962）和长春新碱（NSC-67574）对黑色素瘤转移期进行多药化疗]
Tumori. 1973 May-Jun;59(3):239-48. doi: 10.1177/030089167305900305.
4
Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).使用抗肿瘤药物5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）的临床试验。
Cancer Chemother Rep. 1970 Apr;54(2):119-24.
5
Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）治疗播散性黑色素瘤患者的研究。
Cancer Chemother Rep. 1973 Feb;57(1):83-4.
6
5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of advanced acute lymphocytic leukemia in children.
Cancer Chemother Rep. 1972 Aug;56(4):523-6.
7
Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer.
Cancer. 1972 Sep;30(3):654-9. doi: 10.1002/1097-0142(197209)30:3<654::aid-cncr2820300312>3.0.co;2-x.
8
Chemotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and dactinomycin.用二甲基三氮烯咪唑甲酰胺和放线菌素对播散性恶性黑色素瘤进行化疗。
Cancer. 1973 Oct;32(4):756-60. doi: 10.1002/1097-0142(197310)32:4<756::aid-cncr2820320404>3.0.co;2-6.
9
5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.
Eur J Cancer (1965). 1972 Feb;8(1):85-92. doi: 10.1016/0014-2964(72)90087-4.
10
5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）用于胃肠道癌患者。
Cancer Chemother Rep. 1970 Dec;54(6):471-3.

引用本文的文献

1
Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma.干扰素α2b联合达卡巴嗪治疗转移性恶性黑色素瘤的经验
Med Oncol. 1995 Mar;12(1):35-40. doi: 10.1007/BF01571406.
2
Phase II trial of fotemustine in patients with metastatic malignant melanoma.福莫司汀治疗转移性恶性黑色素瘤患者的II期试验。
Invest New Drugs. 1994;12(3):251-4. doi: 10.1007/BF00873967.
3
[Carcinogenic activity of 13 aryldialkyl triazenes in BD-rats (author's transl)].13种芳基二烷基三氮烯对BD大鼠的致癌活性（作者译）
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1974;81(3-4):285-310. doi: 10.1007/BF00305031.